Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 1 of 1
View Don Davies Profile
In March, you wrote an op-ed. I'll quote from it. You said:
Canada may not even have to depend on commercial partners to bring medical innovation from the lab bench to the patient's bedside. The experience of the Ebola vaccine's development shows that public sector researchers did much of the heavy lifting in the development and even manufacturing of early batches of the vaccine. We have experts in clinical trials in our hospitals, universities and vaccine research groups who are more than capable of doing the necessary clinical trials to develop and deliver new health technologies quickly and affordably.
In your view, would a public drug and vaccine manufacturer of the kind Canada used to have with Connaught Labs help ensure affordability and the development of medications and vaccines that are developed, obviously, through public funding?
Result: 1 - 1 of 1

Export As: XML CSV RSS

For more data options, please see Open Data